Julie Krop
2016
In 2016, Julie Krop earned a total compensation of $1M as Chief Medical Officer and Senior Vice President, Clinical and Regulatory Affairs at AMAG Pharmaceuticals, a 62% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $160,800 |
|---|---|
| Option Awards | $246,650 |
| Salary | $398,615 |
| Stock Awards | $226,620 |
| Other | $7,950 |
| Total | $1,040,635 |
Krop received $398.6K in salary, accounting for 38% of the total pay in 2016.
Krop also received $160.8K in non-equity incentive plan, $246.7K in option awards, $226.6K in stock awards and $8K in other compensation.
Rankings
In 2016, Julie Krop's compensation ranked 8,048th out of 14,075 executives tracked by ExecPay. In other words, Krop earned more than 42.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,048 out of 14,075 | 43rd |
Division Manufacturing | 3,075 out of 5,486 | 44th |
Major group Chemicals And Allied Products | 1,024 out of 1,900 | 46th |
Industry group Drugs | 794 out of 1,543 | 49th |
Industry Pharmaceutical Preparations | 628 out of 1,173 | 47th |
Source: SEC filing on April 20, 2017.
Krop's colleagues
We found five more compensation records of executives who worked with Julie Krop at AMAG Pharmaceuticals in 2016.
2016
William Heiden
AMAG Pharmaceuticals
Chief Executive Officer
2016
Nicholas Grund
AMAG Pharmaceuticals
Chief Commercial Officer
2016
Frank Thomas
AMAG Pharmaceuticals
Chief Operating Officer
2016
Edward Myles
AMAG Pharmaceuticals
Chief Financial Officer
2016
Joseph Vittiglio
AMAG Pharmaceuticals